Literature DB >> 8783371

Which cardiac potassium channel subtype is the preferable target for suppression of ventricular arrhythmias?

S Rees1, M J Curtis.   

Abstract

Prolongation of the cardiac action potential duration is the hallmark of Class III antiarrhythmic activity. Action potential duration prolongation may be achieved by several means: enhancement of inward current and, more commonly, blockade of one or more of the many outward currents that are carried by K+. However, it is far from clear whether blockade of one particular K+ channel is more efficacious than blockade of another. The objective of this review is to consider this question with particular reference to ischaemic heart disease, a condition for which effective prevention of ventricular arrhythmias continues to be sought.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783371     DOI: 10.1016/0163-7258(95)02063-2

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  8 in total

1.  Inactivation block of the HERG human cardiac K+ channels by RP58866.

Authors:  H Wang; H Shi; Z Wang
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 2.  Principles of safety pharmacology.

Authors:  M K Pugsley; S Authier; M J Curtis
Journal:  Br J Pharmacol       Date:  2008-07-07       Impact factor: 8.739

3.  The erg-like potassium current in rat lactotrophs.

Authors:  R Schäfer; I Wulfsen; S Behrens; F Weinsberg; C K Bauer; J R Schwarz
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

4.  Nupafant, a PAF-antagonist prototype for suppression of ventricular fibrillation without liability for QT prolongation?

Authors:  K E Baker; L M Wood; M Whittaker; M J Curtis
Journal:  Br J Pharmacol       Date:  2006-08-21       Impact factor: 8.739

5.  Independent contribution of catecholamines to arrhythmogenesis during evolving infarction in the isolated rat heart.

Authors:  Hugh Clements-Jewery; David J Hearse; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

6.  Feasibility of targeting ischaemia-related ventricular arrhythmias by mimicry of endogenous protection by endocannabinoids.

Authors:  Ellen Andrag; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

7.  Ionic mechanisms of desflurane on prolongation of action potential duration in rat ventricular myocytes.

Authors:  Jee Eun Chae; Hyun Soo Kim; Duck Sun Ahn; Wyun Kon Park
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

8.  Mechanism of doxorubicin cardiotoxicity evaluated by integrating multiple molecular effects into a biophysical model.

Authors:  M Fernandez-Chas; M J Curtis; S A Niederer
Journal:  Br J Pharmacol       Date:  2018-01-23       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.